Loading the player...
Information
Peptides & Rheumatology Update
Length: 1 Hour 31 Minutes
This program will expire and must be completed by 12/15/28.
Learning Objectives:
• Discuss the fundamental approach to Long COVID recovery.
• Explain the immunosenescence in Long COVID and how to restore immunocompetence.
• Describe mitochondrial dysfunction and mitochondria recovery in Long COVID.
• Explore the role of senescent cells in Long COVID and senolytic therapies.
• Discuss the use of peptide bioregulators for the restoration of biologic optimization.
Accreditation Statements:
A.T. Still University (ATSU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
ATSU designates this activity for a maximum of 1.5 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
Osteopathic Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Robert Jackson, DO, FACOI
Dr. Robert Jackson graduated from A.T. Still University-Kirksville College of Osteopathic Medicine (ATSU-KCOM) in 1981 and served as associate dean of Academic Affairs, and as chairman and associate professor of internal medicine at ATSU-KCOM. Dr. Jackson also completed a four-year tour of duty with National Health Service Corps in rural southern Missouri.
Dr. Jackson is currently president of Premier Specialty Network (PSN) and is a full time PSN rheumatologist, practicing at nine different hospitals in Missouri and Iowa. Founded by Dr. Jackson in 1999, PSN has proudly provided quality healthcare to rural communities throughout the United States by establishing satellite clinics staffed by top level doctors. PSN originally evolved out of Northeast Missouri Rural Health Network (NMRHN). While directing NMRHN, Dr. Jackson became acutely aware of the need to improve access to rural healthcare. With his guidance and leadership, NMRHN helped develop five Critical Access Hospitals in northeast Missouri (Unionville, Milan, Macon, Memphis and Brookfield). Subsequently, Dr. Jackson developed a unique model of outreach specialty medical service for rheumatology to serve the same hospitals. PSN has since expanded this and now provides a variety of medical and surgical services to communities across the United States.
Dr. Jackson is board certified in the specialty of internal medicine, as well as in the subspecialty of rheumatology.
Dr. Jackson discloses he is on the Speakers' Bureau for Mallinckrodt Pharmaceuticals and Sanofi, both of which are not relevant conflicts of interest for this presentation.
